Brief: Valion Bio Reports First Quarter 2026 Financial Results
May 14 (Reuters) - Valion Bio Inc VBIO.O: VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS VALION BIO INC - Q1 2026 NET LOSS $2.23 PER SHARE Source text: ID:nPn28kJ3da Further company coverage: VBIO.O ((Reuters.Briefs@thomsonreuters.com;))